文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

作者信息

Raulet David H, Guerra Nadia

机构信息

Department of Molecular and Cell Biology, Cancer Research Laboratory, 485 Life Science Addition, University of California, Berkeley, California 94720, USA.

出版信息

Nat Rev Immunol. 2009 Aug;9(8):568-80. doi: 10.1038/nri2604.


DOI:10.1038/nri2604
PMID:19629084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3017432/
Abstract

A growing body of research is addressing how pathways that are dysregulated during tumorigenesis are linked to innate immune responses, which can contribute to immune surveillance of cancer. Components of the innate immune system that are localized in tissues are thought to eliminate early neoplastic cells, thereby preventing or delaying the establishment of advanced tumours. This Review addresses our current understanding of the mechanisms that detect cellular stresses that are associated with tumorigenesis and that culminate in the recognition and, in some cases, the elimination of the tumour cells by natural killer cells and other lymphocytes that express natural killer cell receptors.

摘要

相似文献

[1]
Oncogenic stress sensed by the immune system: role of natural killer cell receptors.

Nat Rev Immunol. 2009-8

[2]
Human innate immunosenescence: causes and consequences for immunity in old age.

Trends Immunol. 2009-7

[3]
Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).

Rinsho Ketsueki. 2009-5

[4]
The role of natural killer cells in cancer therapy.

Front Biosci (Elite Ed). 2010-1-1

[5]
A notch in the toll belt.

Immunity. 2008-11-14

[6]
The role of natural killer cells in autoimmune liver disease: a comprehensive review.

J Autoimmun. 2013-7-21

[7]
Immunosurveillance and immunotherapy of tumors by innate immune cells.

Curr Opin Immunol. 2016-2

[8]
Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance.

Cancer Immunol Immunother. 2016-4

[9]
Dendritic cell interactions with NK cells from different tissues.

J Clin Immunol. 2009-5

[10]
The role of natural killer cells in hepatitis C infection.

Antivir Ther. 2013

引用本文的文献

[1]
Immunomodulatory effects of photothermal therapy in breast cancer: advances and challenges.

Front Immunol. 2025-7-4

[2]
Rendering NK Cells Antigen-Specific for the Therapy of Solid Tumours.

Int J Mol Sci. 2025-6-29

[3]
Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics.

Front Immunol. 2025-4-10

[4]
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease.

Front Immunol. 2025-4-4

[5]
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies.

Stem Cell Res Ther. 2025-1-7

[6]
Emerging Insights into Memory Natural Killer Cells and Clinical Applications.

Viruses. 2024-11-7

[7]
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapy.

bioRxiv. 2024-10-15

[8]
Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor-Associated Immune Cell Signatures and Immuno Nano Sensors.

Small. 2024-12

[9]
A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy.

Immunotargets Ther. 2024-10-10

[10]
A battle between two biological singularities: Immune response vs. cancer.

Biophys Physicobiol. 2024-2-9

本文引用的文献

[1]
Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin.

J Immunol. 2009-4-15

[2]
Type I natural killer T cells suppress tumors caused by p53 loss in mice.

Blood. 2009-6-18

[3]
Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1.

J Immunol. 2009-2-15

[4]
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.

J Exp Med. 2009-2-16

[5]
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate.

Leukemia. 2009-4

[6]
Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation.

Clin Cancer Res. 2009-1-15

[7]
Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.

Blood. 2009-3-26

[8]
Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.

J Immunol. 2009-1-1

[9]
Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein.

J Immunol. 2009-1-1

[10]
Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA.

J Immunol. 2009-1-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索